Chairman Michael J. Farrell - 18 Aug 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
18 Aug 2022
Net transactions value
$0
Form type
4
Filing time
22 Aug 2022, 15:06:21 UTC
Previous filing
17 Aug 2022
Next filing
19 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +17,310 +4.3% $0.000000 422,570 18 Aug 2022 Direct F1
holding RMD ResMed Common Stock 3,880 18 Aug 2022 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 5,090 18 Aug 2022 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.